Eton Pharmaceuticals Inc (ETON)
5.80
+0.12
(+2.11%)
USD |
NASDAQ |
Sep 27, 16:00
5.800
0.00 (0.00%)
After-Hours: 20:00
Eton Pharmaceuticals Gross Profit (TTM): 18.67M for June 30, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 18.67M |
March 31, 2024 | 22.72M |
December 31, 2023 | 21.06M |
September 30, 2023 | 23.79M |
June 30, 2023 | 21.41M |
March 31, 2023 | 16.34M |
December 31, 2022 | 14.32M |
September 30, 2022 | 13.68M |
June 30, 2022 | 11.78M |
March 31, 2022 | 10.06M |
Date | Value |
---|---|
December 31, 2021 | 19.04M |
September 30, 2021 | 12.95M |
June 30, 2021 | 12.81M |
March 31, 2021 | 9.913M |
December 31, 2020 | -0.397M |
September 30, 2020 | -0.022M |
June 30, 2020 | -0.005M |
March 31, 2020 | 0.003M |
December 31, 2019 | 0.506M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
-0.397M
Minimum
Dec 2020
23.79M
Maximum
Sep 2023
12.03M
Average
12.95M
Median
Sep 2021
Gross Profit (TTM) Benchmarks
Biomarin Pharmaceutical Inc | 2.073B |
Integra Lifesciences Holdings Corp | 877.59M |
Elutia Inc | 10.61M |
Immuneering Corp | -- |
Journey Medical Corp | 51.88M |